Financhill
Back

Krystal Biotech 10K Form

Sell
50

KRYS
Krystal Biotech

Last Price:
178.08
Seasonality Move:
27.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KRYS News And Ratings

See the #1 stock for the next 7 days that we like better than KRYS

KRYS Financial Statistics

Sales & Book Value

Annual Sales: $50.7M
Cash Flow: $-9.08M
Price / Cash Flow: 0
Annual Sales: $27.58
Price / Book: 6.43

Profitability

EPS (TTM): 0.09000
Net Income (TTM): $10.93M
Gross Margin: $47.61M
Return on Equity: 0%
Return on Assets: 0%

Krystal Biotech Earnings Forecast

Key Krystal Biotech Financial Ratios

  • The Gross Profit Margin over the past 3 years for KRYS is 93.90%.
  • The Selling, General & Administrative Expenses for KRYS have been equal to 194.09% of Gross Profit Margin.
  • The Research & Development expenses have been 91.58% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of KRYS is 21.56% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Krystal Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: KRYS
CUSIP: 501147
Website: krystalbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 17.76
Quick Ratio: 17.35

Price-to-Earnings

Trailing P/E Ratio: 453.95
Forward P/E Ratio: 35.11

KRYS Technical Analysis vs Fundamental Analysis

Sell
50
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy or a Sell?

  • Krystal Biotech stock is rated a Sell
    The current Krystal Biotech [KRYS] share price is $177.04. The Score for KRYS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.